Stocks · Health care · Pharmaceutical Preparations

InflaRx N.V.

IFRX Clue Score13
Germany Fiscal year ends December CIK 0001708688
$1.60 +4.58% Close, 9 Oct 2026
Price $1.60 −36.76% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 7 Nov 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Net income−8.9Fiscal year 2017Net income−24.2Fiscal year 2018Net income−29.8Fiscal year 2019Net income−53.3Fiscal year 2020Net income−34.0EPS, diluted−1.26Fiscal year 2021Operating income−47.6Net income−45.6EPS, diluted−1.10Fiscal year 2022Operating income−32.2Net income−29.5EPS, diluted−0.67Fiscal year 2023Revenue0.1Operating income−44.9Net income−42.7EPS, diluted−0.78Fiscal year 2024Revenue0.2 +162.8%Net income−46.1EPS, diluted−0.78Fiscal year 2025Revenue0.0 −82.3%Net income−45.6EPS, diluted−0.68
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a n/a n/a n/a 0.1 0.2 0.0
Growth +162.8% −82.3%
Operating income n/a n/a n/a n/a n/a −47.6 −32.2 −44.9 n/a n/a
Net income −8.9 −24.2 −29.8 −53.3 −34.0 −45.6 −29.5 −42.7 −46.1 −45.6
Growth
EPS, diluted n/a n/a n/a n/a −1.26 −1.10 −0.67 −0.78 −0.78 −0.68

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Gross margin−743.7%Operating margin−71,182.1%Net margin−67,630.7%Fiscal year 2024Gross margin−1,900.8%Net margin−27,785.0%Fiscal year 2025Gross margin−24,677.9%Net margin−155,582.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a n/a n/a −743.7% −1,900.8% −24,677.9%
Operating margin n/a n/a n/a n/a n/a n/a n/a −71,182.1% n/a n/a
Net margin n/a n/a n/a n/a n/a n/a n/a −67,630.7% −27,785.0% −155,582.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2016Operating cash flow−5.0Fiscal year 2017Operating cash flow−12.2Fiscal year 2018Operating cash flow−21.5Fiscal year 2019Operating cash flow−43.2Fiscal year 2020Operating cash flow−36.5Fiscal year 2021Operating cash flow−39.9Fiscal year 2022Operating cash flow−33.7Fiscal year 2023Operating cash flow−37.8Fiscal year 2024Operating cash flow−48.6Fiscal year 2025Operating cash flow−35.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.0 −12.2 −21.5 −43.2 −36.5 −39.9 −33.7 −37.8 −48.6 −35.3

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash29.1Shareholders’ equity−25.7Fiscal year 2017Cash123.3Shareholders’ equity119.4Fiscal year 2018Cash55.4Shareholders’ equity151.4Fiscal year 2019Cash33.1Shareholders’ equity107.1Fiscal year 2020Cash26.0Shareholders’ equity77.9Fiscal year 2021Cash26.2Total debt0.0Net cash (debt)26.2Shareholders’ equity3.1Debt to equity0.00Fiscal year 2022Cash16.3Shareholders’ equity7.3Fiscal year 2023Cash12.8Shareholders’ equity7.4Fiscal year 2024Cash18.4Shareholders’ equity7.4Fiscal year 2025Cash16.0Shareholders’ equity7.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 29.1 123.3 55.4 33.1 26.0 26.2 16.3 12.8 18.4 16.0
Total debt n/a n/a n/a n/a n/a 0.0 n/a n/a n/a n/a
Net cash (debt) n/a n/a n/a n/a n/a 26.2 n/a n/a n/a n/a
Shareholders’ equity −25.7 119.4 151.4 107.1 77.9 3.1 7.3 7.4 7.4 7.2
Debt to equity n/a n/a n/a n/a n/a 0.00 n/a n/a n/a n/a

In millions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017† 31 Dec 2017 FY2018† 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a n/a n/a n/a n/a n/a 0.1 0.2 0.0
Growth +162.8% −82.3%
n/a n/a n/a n/a n/a n/a n/a 0.5 3.3 7.3
−7.1 −19.6 −37.8 n/a n/a n/a n/a −0.5 −3.2 −7.2
Growth
5.3 14.4 25.0 44.6 25.7 35.7 37.5 41.0 35.4 25.7
1.8 5.1 12.8 12.5 8.5 0.1 0.1 0.1 0.0 0.0
n/a n/a n/a n/a n/a −47.6 −32.2 −44.9 n/a n/a
Growth
−8.9 −24.2 −29.8 −53.3 −34.0 −45.6 −29.5 −42.7 −46.1 −45.6
0.0 0.0 0.0 0.0 0.0 0.0 n/a n/a 0.0 0.0
−8.9 −24.2 −29.8 −53.3 −34.0 −45.6 −29.5 −42.7 −46.1 −45.6
Growth
Per share
n/a n/a n/a n/a −1.26 −1.10 −0.67 −0.78 −0.78 −0.68
n/a n/a n/a n/a −1.26 −1.10 −0.67 −0.78 −0.78 −0.68
Growth
n/a n/a n/a 26.0 27.1 41.6 44.2 54.9 58.9 67.3
0.0 9.4 25.1 26.0 27.1 41.6 n/a n/a n/a n/a
Growth +398,144.8% +166.7% +3.6% +4.1% +53.8%

† The diluted share count jumps at 2017 and 2018 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Shown in EUR as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.